xocova
Xocova (Ensitrelvir) for COVID-19 Post-Exposure Prophylaxis: What the Evidence Actually Shows — and What It Doesn't
Yoon Hang Kim MD Board-Certified Preventive Medicine | Integrative & Functional Medicine November 2026 Abstract Ensitrelvir (Xocova) is an oral SARS-CoV-2 3CL main protease inhibitor that, unlike nirmatrelvir/ritonavir (Paxlovid), is given without a ritonavir booster. In the United States it is approved for post-exposure prophylaxis in